CVS Health Corporation (CVS) Business Profile

What it does

CVS Health is a health care company that combines health insurance, pharmacy benefit management, care delivery and retail pharmacy businesses. It was founded in 1963, is headquartered in Rhode Island and is led by President and Chief Executive Officer J. David Joyner.

Its Health Care Benefits segment operates through Aetna and offers medical, pharmacy, dental and behavioral-health plans, along with Medicare Advantage, Medicare Supplement, Medicare Part D and Medicaid services. These plans are sold to employers, governments and individuals. In insured plans, CVS Health bears most or all of the medical-cost risk; in administrative-services contracts, the employer or plan sponsor bears most of that risk.

Its Health Services segment runs CVS Caremark, which designs and administers pharmacy benefits, manages drug formularies and pharmacy networks, and operates specialty and mail-order pharmacy services. It also provides care in clinics, virtually and in patients’ homes, including through Signify Health and Oak Street Health.

Its Pharmacy & Consumer Wellness segment fills prescriptions, administers vaccinations, provides pharmacy patient-care programs and sells health, wellness and general merchandise through CVS Pharmacy locations and online channels. CVS Health had approximately 9,000 retail locations and more than 1,000 walk-in and primary-care clinics as of December 31, 2025. It employed 300,000 people in FY2025.

How it makes money

CVS Health earns revenue in four segments. Health Care Benefits collects premiums from insured health plans and receives fees for administrative-services contracts. For commercial insured plans, premiums are generally fixed for a policy period of one year, so unanticipated medical-cost increases generally cannot be recovered until later pricing periods. Medicare Advantage and Part D revenue includes fixed per-member payments and premiums that are revised annually by CMS; Medicaid contracts generally pay fixed monthly rates per member.

Health Services earns most of its revenue from selling and managing prescription drugs for members of client benefit plans. Caremark earns from plan administration, formulary management, pharmacy network management, specialty and mail-order dispensing, clinical programs and group-purchasing services. The segment also has value-based care arrangements with payors and CMS.

Pharmacy & Consumer Wellness generates prescription revenue at retail pharmacies, through infusion operations and through fulfillment services for Health Services. It also sells front-store merchandise. Pharmacy represented 82.9% of this segment’s revenue in 2025, with front store and other representing 17.1%.

For the latest reported quarter, CVS Health generated over $106 billion of revenue in Q2 2026. The consensus for the current fiscal year is $418.2 billion of revenue and $8.02 of EPS.

Customers and how it sells

CVS Health serves health-plan members, employers, insurers, unions, government employee groups, health plans, Medicare Part D plans, Medicaid managed-care plans, government agencies, providers, covered entities and retail pharmacy customers. Aetna served an estimated more than 37 million people through insurance products and related services as of December 31, 2025. CVS Health’s pharmacy benefit manager had approximately 87 million plan members.

Health plans reach members mainly through employer groups, government-sponsored plans and individual coverage. Commercial products are sold through CVS Health sales personnel, brokers, agents, consultants and private exchanges. Retail pharmacy customers use stores, online pharmacy sites, specialty pharmacies, mail-order services, infusion operations and clinics.

The business is principally U.S.-based. Pharmacy network operations cover the U.S., Puerto Rico, the District of Columbia, Guam and the U.S. Virgin Islands. Medicare Advantage products were offered in 44 states and Washington, D.C. in 2025, while Medicare Part D plans were offered in all 50 states and Washington, D.C.

The U.S. federal government is a significant customer through Medicare and federal employee-related programs. CVS Health exited the states where Aetna offered individual public-exchange plans effective January 2026.

Suppliers and costs

CVS Health buys merchandise from numerous manufacturers and distributors for its retail business, and states that competitive sources are readily available for substantially all products carried in its stores. Its pharmacy benefit business negotiates pharmaceutical purchase pricing and rebates with drug manufacturers, while its retail and mail-order operations acquire and dispense prescription drugs.

Medical and other benefit costs are a major expense in the insurance business. CVS Health contracts with physicians, hospitals and other providers for member care, using negotiated reimbursement rates, utilization-management practices and risk-sharing arrangements. Drug mix, brand inflation, pharmacy reimbursement pressure, manufacturer rebates and retail-network discounts also affect results.

Operating costs include store and clinic staffing, pharmacists and other clinicians, technology, claims administration, distribution, rent, marketing and corporate functions. CVS Health expects elevated medical utilization to persist in 2026, although it states that the level of utilization is difficult to predict. The company also faces pressure to share more manufacturer rebates, fees and discounts with clients.

Competitive position

CVS Health competes across several markets. In health insurance, competition includes local and regional plans, large commercial insurers, Blue Cross and Blue Shield licensees, provider-owned plans, third-party administrators and government programs; Original Medicare is the largest competitor in Medicare products. Health-plan competition turns on coverage, premiums, provider networks, service, care management, quality, financial strength and technology.

Caremark competes in pharmacy benefit management with Prime Therapeutics, MedImpact, Express Scripts, a Cigna Corporation business, and Optum Rx, a UnitedHealth Group business, as well as smaller PBMs. Its clinics compete with retail clinics, urgent-care providers and primary-care offices. Its value-based primary-care operations compete with local and national primary-care providers and health-system-affiliated practices.

CVS Pharmacy competes with Walgreens, Walmart, Amazon, supermarkets, independent pharmacies, mail-order pharmacies, membership clubs and other drugstore chains. Competition focuses on location, convenience, service, assortment and price.

Our reading: CVS Health’s retail footprint, Aetna membership base, Caremark plan-member scale and connected insurance, PBM, care and pharmacy operations are meaningful operating advantages, because they link payer, provider and dispensing capabilities. They do not remove competitive pressure on pricing, reimbursements or client retention.

Our reading: The moat from the pharmacy network and technology is moderate rather than exclusive: competing national PBMs and pharmacies operate at scale, while employers, health plans and consumers have alternative channels.

Growth opportunities

CVS Health is developing growth around its combined insurance, PBM, specialty pharmacy, retail pharmacy and care-delivery operations. Health Services filled or managed 1.9 billion prescriptions on a 30-day equivalent basis in 2025, while Pharmacy & Consumer Wellness filled 1.8 billion prescriptions on the same basis. CVS Health also dispensed approximately 28.5% of U.S. retail pharmacy prescriptions in 2025.

The company is expanding specialty pharmacy, biosimilars, value-based primary care, in-home health-risk assessments and digital care tools. It has introduced Health100, including the HIO AI-powered assistant, in a targeted launch and expects to expand access later in 2026. CVS Health has also launched an AI-enabled claims-assist manager that it expects will reduce processing time by over 20% and accelerate provider payments on hundreds of millions of claims annually.

GLP-1 medicines are another growth focus across Caremark, Aetna, MinuteClinic and CVS Pharmacy. CVS Health partnered with Eli Lilly to provide eligible Zepbound and Mounjaro patients access to cash-pay pricing and same-day pickup later in 2026. It also has a relationship with Novo Nordisk to dispense oral and injectable Wegovy products.

For 2026, CVS Health expects total revenue of at least $414 billion and adjusted EPS of $7.90 to $8.10. It expects at least $11.5 billion of cash flow from operations.

Structural risks

• Medical-cost forecasting: CVS Health may not accurately forecast health care and other benefit costs. Higher utilization, disease outbreaks and changes in care patterns can pressure insurance and care-delivery results, particularly where premiums or capitation rates are set in advance.

• Government exposure: Medicare, Medicaid and other government programs are subject to funding, reimbursement, risk-adjustment, quality-rating and regulatory changes.

• PBM economics and regulation: CVS Health expects pressure from a larger sharing of manufacturer rebates, fees and discounts with clients. Laws and regulations governing PBMs could affect its ability to operate on commercially reasonable terms and standardize services across states.

• Competition and reimbursement: All three operating businesses compete in pricing, premiums, pharmacy reimbursement, provider access, customer service and product design. New entrants, digital channels and self-funded employer health plans can affect membership, pharmacy volume and margins.

• Technology and information security: Data-governance failures, technology disruption, cyberattacks or other information-security incidents can affect operations, reputation and business prospects.

• Drug supply and pricing: Prescription-drug availability, manufacturer pricing, inflation, supply disruptions, safety restrictions, generic introductions and changes in manufacturer participation in government programs can affect costs and revenue.

Bottom line

Our reading

Our reading: CVS Health is a U.S. health care intermediary and service provider whose earnings come from underwriting health benefits, administering and dispensing prescription drugs, and operating retail and care-delivery channels. Its scale spans Aetna, Caremark, approximately 9,000 pharmacy locations and large prescription volumes, but its business remains exposed to medical-cost trends, government reimbursement, PBM regulation and pricing competition. The company’s technology, specialty pharmacy and GLP-1 initiatives extend its existing channels rather than creating a separate business model.